Aetna Denied My Prior Authorization for hEDS/EDS Specialty PT. Here's What Your Appeal Needs.
When a prior authorization for hypermobile EDS specialty physical therapy comes back denied, the reason printed on the letter is rarely the whole story. The denial often turns on a procedural gap — and procedural gaps are where appeals are won.
Free Record Check available now. No guarantee of coverage or approval.
- "Not medically necessary" on an EDS PT prior auth is a conclusion, not the reasoning. The carrier still owes you the specific clinical criteria it applied and the records it reviewed.
- Specialty PT for hypermobile EDS is often denied against generic musculoskeletal guidelines that do not account for connective-tissue disorders. Naming that mismatch is the appeal.
- The most common procedural gap: the reviewer who issued the denial may not be a same-or-similar specialty clinician, and the criteria set may never have been disclosed to you.
- You are entitled to the clinical rationale, the guideline or criteria used, and the reviewer's credentials — in writing — before you write a single word of clinical rebuttal.
- A peer-to-peer review and a documented criteria request frequently move these denials faster than a long clinical letter.
I am a patient, not a doctor or a lawyer. I built this because I needed it — I lived the experience of having specialized care treated as optional by a system that never looked closely at the diagnosis. With a connective-tissue condition, the denials rarely said the care was wrong; they said the paperwork did not satisfy a checklist I was never shown. What changed things was getting the carrier to put the checklist, and who applied it, on the record. That is the move this page is about.
Why EDS Specialty PT Denials Are Usually Procedural, Not Clinical
Hypermobile Ehlers-Danlos syndrome is a connective-tissue disorder. The physical therapy that helps — careful, progressive, joint-protective work delivered by a clinician who understands hypermobility — looks different from the standard post-injury PT protocol an insurer's review software is calibrated against. When Aetna runs your prior authorization against a generic musculoskeletal guideline, the request can fail not because the care is inappropriate but because the guideline was never designed for your condition. The letter then says "not medically necessary," which sounds like a clinical judgment but is often the output of a criteria mismatch.
That distinction is the whole game. If you treat the denial as a clinical disagreement, you end up writing a long letter arguing that your care is good medicine — a letter the carrier can answer with the same generic guideline. If you treat it as a procedural problem, you start asking different, sharper questions: which specific criteria set did you apply, what were its exact requirements, which records did the reviewer actually read, and what were the reviewer's clinical credentials? Those questions are harder for the carrier to deflect, because the answers are either in your file or they are not.
For employer-sponsored plans governed by ERISA, the claims-procedure rule at 29 CFR 2560.503-1 sets out what a denial must contain and what you can demand. An adverse determination has to give you the specific reason for the denial and reference the specific plan provisions on which it is based. If an internal rule, guideline, or clinical criterion was relied on, you are entitled to a copy of it free of charge on request. And for claims involving medical judgment, the plan must identify the medical or scientific basis for the decision and, on appeal, the review must be conducted by a clinician who was not involved in the original denial. Many members never ask for any of this — so they never learn that the "medical necessity" call was made against a guideline that does not fit their diagnosis, sometimes by a reviewer outside the relevant specialty.
There is a parity dimension worth knowing about too. The Mental Health Parity and Addiction Equity Act, described by the U.S. Department of Labor, restricts how plans can apply non-quantitative treatment limitations — including medical-necessity criteria and prior-authorization requirements — more stringently to certain benefits than to comparable ones. Parity analysis is most associated with behavioral health, but the underlying principle, that treatment limitations must be applied even-handedly and transparently, is part of why the "show me the exact criteria you applied and how you applied it" question carries weight. The carrier is not supposed to hold your care to an undisclosed, harder standard than it holds comparable care.
The practical upshot is that the strongest EDS PT appeal usually starts before any clinical argument. It starts by forcing three things into your written record: the exact criteria set Aetna applied, the records the reviewer actually reviewed, and the reviewer's credentials. With the criteria in hand, your clinician can respond to the actual requirements instead of guessing. If the records list is short, you have identified a documentation gap to close. And if the reviewer was not a same-or-similar specialty clinician, you have a procedural ground to demand a proper review on appeal — frequently through a peer-to-peer conversation between your prescribing clinician and an Aetna medical director.
None of this guarantees an approval. What it does is shift the appeal off the carrier's preferred terrain — a vague clinical disagreement they are structured to win — and onto procedural ground where the questions have concrete answers. An appeal that says "your own criteria, which you provided to me on this date, do not address connective-tissue disease, and the reviewer was not a specialist in this area" is a different document from one that pleads that the care is important. The first is built on the carrier's own record. The second is built on hope.
What to Do Next
- Read the denial for the deadline and the reason language. Note your internal appeal window from the date on the letter, and find the exact stated reason.
- Request the criteria and the reviewer's credentials in writing. Ask Aetna for the specific clinical guideline or criteria set applied, a copy of it, and the credentials of the clinician who issued the denial.
- Ask for a peer-to-peer review. Request that your prescribing clinician speak directly with an Aetna medical director, and capture the reference number and scheduling details.
- Confirm what records were actually reviewed. Find out which documents the reviewer had, so you can close any gap before the formal appeal.
- Build the appeal on the criteria, not on sympathy. Have your clinician respond to the exact requirements the carrier disclosed and document any mismatch with a connective-tissue diagnosis.
Where Claim Lane Fits In
Start free. The Record Check reads the denial language, identifies whether you are looking at a procedural gap or a true clinical dispute, and tells you the next written question to ask.
Record Calls are currently in limited testing and are not open for public purchase yet. When available, a Record Call sends an AI calling assistant to Aetna on your behalf, asks for the specific criteria applied, the reviewer's credentials, and the peer-to-peer pathway, and returns the recording, the transcript with identifiers redacted by default, a structured summary, and the captured reference numbers by email.
No outcome is promised. What you get is the documented call — the record of exactly what the carrier said, in a form your clinician can build an appeal around.
Free Record Check available now. No guarantee of coverage or approval. Refunded if a usable artifact cannot be delivered.
Common Questions About EDS Prior-Auth Denials
Why does Aetna call my EDS physical therapy "not medically necessary"?
Often because the request was scored against a generic musculoskeletal guideline that was not written for connective-tissue disorders like hypermobile EDS. The phrase "not medically necessary" is the conclusion; the reasoning is the specific criteria set the reviewer applied. Until you obtain that criteria set in writing, you cannot tell whether the denial reflects your clinical situation or a guideline mismatch.
Can I get the clinical criteria Aetna used to deny my prior authorization?
For ERISA-governed plans, yes. Under 29 CFR 2560.503-1, if an internal rule, guideline, or clinical criterion was relied on in denying your claim, you are entitled to a copy free of charge on request. Asking for it in writing is one of the most effective moves available, because it tells you exactly what your appeal has to answer.
What is a peer-to-peer review and should I request one?
A peer-to-peer review is a direct conversation between your prescribing clinician and a medical director at the carrier. It is frequently faster than a written appeal and gives your clinician a chance to address the actual criteria. Requesting one, and documenting the reference number and outcome, is often a strong early step for specialty-care denials.
Does it matter who reviewed my denial?
It can matter a great deal. For ERISA plans, an appeal of a medical-judgment denial must be reviewed by a clinician who was not involved in the original decision, and carriers are generally expected to use appropriately qualified reviewers. If the original denial was issued by someone outside the relevant specialty, that is a procedural ground to demand a proper review — which is why obtaining the reviewer's credentials in writing matters.
Authoritative source: the ERISA claims-procedure rule, 29 CFR 2560.503-1, on the federal eCFR.
Claim Lane is an administrative record-building tool, not a law firm or legal service. It does not provide legal or medical advice and does not create an attorney-client relationship. Claim Lane is not affiliated with, endorsed by, or sponsored by Aetna or any health insurance carrier. Results are not guaranteed.